← back to search

Paula Stubbemann

Charité - Universitätsmedizin Berlin · DE
Area of research
Infectious Diseases · Neurology
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, and COVID-19 diagnosis using AI.
h-index
14
citations
1,339
works
22
NIH funding
primary concept
email

Recent publications

The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
Cell 2024cited by 27position: middledoi
CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity
Nature Immunology 2023cited by 40position: middledoi
The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation
Journal of Neuroinflammation 2023cited by 38position: middledoi
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Hepatology International 2023cited by 23position: middledoi
Serum neurofilament light chain in COVID-19 and the influence of renal function
European journal of medical research 2023cited by 10position: middledoi
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
JCI Insight 2023cited by 6position: middledoi
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies
Journal of Clinical Immunology 2022cited by 36position: middledoi
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
The Lancet Respiratory Medicine 2021cited by 355position: middledoi
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
Immunity 2021cited by 257position: middledoi
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01
EClinicalMedicine 2021cited by 101position: middledoi
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
Clinical Microbiology and Infection 2021cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Florian Kurth · Swiss Center for Electronics and Microtechnology (Switzerland)2 papers (2023–2023)Matthias Endres · Excellence Cluster Universe1 papers (2023–2023)Thomas Zöller · Humboldt-Universität zu Berlin1 papers (2023–2023)Veronica Di Cristanziano · University of Cologne1 papers (2023–2023)Felix Wohlrab · Max Delbrück Center1 papers (2023–2023)Jan A. Graw · Friedrich-Alexander-Universität Erlangen-Nürnberg1 papers (2023–2023) · 1 papers (2023–2023)Leif Erik Sander · Charité - Universitätsmedizin Berlin1 papers (2023–2023)Mirja Mittermaier · Smith-Kettlewell Eye Research Institute1 papers (2023–2023)Klemens Ruprecht · Heidelberg University1 papers (2023–2023)Jens Kühle · University of Basel1 papers (2023–2023)Tilman Lingscheid · Humboldt-Universität zu Berlin1 papers (2023–2023)Péter Körtvelyessy · German Center for Neurodegenerative Diseases1 papers (2023–2023)Martin Witzenrath · German Centre for Cardiovascular Research1 papers (2023–2023)David Hillus · Humboldt-Universität zu Berlin1 papers (2023–2023)Lara Bardtke · Charité - Universitätsmedizin Berlin1 papers (2023–2023)Kanika Vanshylla · Johnson & Johnson (Netherlands)1 papers (2023–2023)Friederike Münn · Humboldt-Universität zu Berlin1 papers (2023–2023) · 1 papers (2023–2023)Pinkus Tober‐Lau · Charité - Universitätsmedizin Berlin1 papers (2023–2023)